Before you watch this webinar
Enhancing your learning experience begins with understanding you better. Collecting data enables us to tailor our educational content specifically for our audience. Discover more about how we handle your information in our Privacy Policy.
This area of the website is reserved for healthcare professionals as it contains information created for a healthcare professional audience.
Event
Vaccinations in multiple sclerosis – current guidelines and considerations for 2025
Please note: There is restricted access to the live webinars. Access to the live webinars is for health professionals working in MS services and a limited number of pharmaceutical representatives. If you are not granted access to the live webinar, you will be able to review the footage, which will be posted on our website shortly after the webinar has been conducted.
Our sponsor
This webinar has received sponsorship from Novartis Pharmaceuticals UK limited. The first session in the webinar is designed and delivered by the MS Academy and sponsored by Novartis Pharmaceuticals UK limited; the sponsor has had no input into the educational content or organisation of the session. The second session is a promotional satellite symposium that is organised and funded by Novartis Pharmaceuticals UK limited. This satellite symposium is for UK Healthcare Professionals only.
MS Academy will host a live webinar on Tuesday 29th April at 14:15. You are invited to watch the webinar from your computer or tablet. We will be live for 1 hour and 25 minutes via Zoom and a recording of the MS Academy session will be available following the meeting.
14.15 - 14:58 MS Academy webinar
As multiple sclerosis (MS) care evolves, so too does our understanding of how vaccinations impact patients living with the condition, particularly those on disease-modifying therapies (DMTs). This 45-minute webinar will provide healthcare professionals with the latest guidelines and best practices for vaccination in MS patients, highlighting key updates for 2025.
Webinar objectives
- Understand the role of vaccinations in MS care
- Review current vaccination guidelines
- Vaccination timing and disease modifying therapies (DMTs)
- Addressing common concerns and misconceptions
- Patient education and communication strategies
14:58 - 15:00 Break
15:00 - 15:40 Novartis promotional satellite symposium
This webinar has received sponsorship from Novartis Pharmaceuticals UK limited. The first session in the webinar is designed and delivered by the MS Academy and sponsored by Novartis Pharmaceuticals UK limited; the sponsor has had no input into the educational content or organisation of the session. The second session is a promotional satellite symposium that is organised and funded by Novartis Pharmaceuticals UK limited. This satellite symposium is for UK Healthcare Professionals only.
Novartis promotional satellite symposium:
Prescribing information for KESIMPTA®▼(ofatumumab) can be found here. Adverse Events Reporting information can be found below the speakers information.
KESIMPTA® is indicated for the treatment of adult patients with relapsing forms of multiple sclerosis (RMS) with active disease defined by clinical or imaging features.
Building Sustainable MS Services: Exploring the Role of KESIMPTA®▼(ofatumumab) in Optimising Patient Care
Join Dr Waqar Rashid and Jennifer Slough as they delve into the evolution in MS care and the role of KESIMPTA®▼(ofatumumab) data and share their own clinical experience of managing their RRMS patient cohort, being treated with KESIMPTA®.
Dr Waqar Rashid
Consultant neurologist, St George's University Hospitals NHS Foundation Trust
Jennifer Slough
Clinical Nurse Specialist, University College London Hospitals NHS Foundation Trust
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard.
Adverse events should also be reported to Novartis online through the pharmacovigilance intake (PVI) tool at www.novartis.com/report or alternatively email medinfo.uk@novartis.com or call 01276 698370.
UK | March 2025 | FA-11368357
This event is free to attend as a result of sponsorship from our sponsors. The current event sponsors are listed on this page. In the interest of Neurology Academy and our sponsors’ legitimate business interests, we make available your name, job title and workplace to our sponsors. It allows us to attract the most appropriate sponsors, delegates and speakers for the events and to facilitate potential collaboration and communication between you and the sponsors; and allows us to offer other relevant events and services to the healthcare and life science industries. You can ask us not to share your name, job title and workplace by emailing info@neurologyacademy.org. We respect the privacy of every person for whom we have personal data. The group privacy and cookies policy can be viewed here.
Book your place now
Our sponsor
This webinar has received sponsorship from Novartis Pharmaceuticals UK limited. The first session in the webinar is designed and delivered by the MS Academy and sponsored by Novartis Pharmaceuticals UK limited; the sponsor has had no input into the educational content or organisation of the session. The second session is a promotional satellite symposium that is organised and funded by Novartis Pharmaceuticals UK limited. This satellite symposium is for UK Healthcare Professionals only.
CPD accreditation
We will apply for CPD accreditation from the Royal College of Physicians for this webinar.
Please note CPD Federation approval does not include satellite symposia sessions.
Chair
Dr David PalingHonorary strategic director, MS Academy & consultant neurologist, Sheffield Teaching Hospitals NHS Foundation Trust
Speakers
Dr Saúl ReyesConsultant neurologist & honorary clinical lecturer, Queen Mary University of London
Joela MathewsHighly specialist pharmacist – neurosciences lead, Barts Health NHS Trust
Encouraging excellence, developing leaders, inspiring change
MS Academy was established five years ago and in that time has accomplished a huge amount. The six different levels of specialist MS training are dedicated to case-based learning and practical application of cutting edge research. Home to national programme Raising the Bar and the fantastic workstream content it is producing, this is an exciting Academy to belong to.